R906289 Monosodium

Treatment Description

R906289 Monosodium is a small molecule IRAK1 and IRAK4 inhibitor currently being studied for use in myelodysplastic syndrome (MDS).

There are 9 centers running trials with this treatment. Enter a location below to find the closest center.